On January 25, 2012, the Massachusetts Life Sciences Center announced a $5 million grant to the Joslin Diabetes Center. The grant and matching funds will be used to build an innovative Translational Center for the Cure of Diabetes.
On January 25, 2012, the Massachusetts Life Sciences Center announced a $5 million grant to the Joslin Diabetes Center. The grant and matching funds will be used to build an innovative Translational Center for the Cure of Diabetes.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.